Immunotherapy Breakthroughs
Discover how the number of mutations in cancers, particularly melanoma and pancreatic cancer, influences the effectiveness of immunotherapy. A compelling case illustrates the potential of checkpoint inhibitors, showcasing a patient who achieved complete cancer regression but faced the unexpected consequence of losing his pancreas. The discussion also raises intriguing questions about the relationship between autoimmunity and treatment response.In this clip
From this podcast
Huberman Lab
Journal Club with Dr. Peter Attia | Effects of Light & Dark on Mental Health & Treatments for Cancer
Related Questions